APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rapid Influenza Diagnostic Test (RIDT)

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Selected research

Market Outlook & Growth Opportunities

Global Rapid Influenza Diagnostic Test (RIDT) Market Outlook and Growth Opportunities 2026

Report ID 173920700419 December 2025193 pages

Choose your research edition.

Industry ResearchRapid Influenza Diagnostic Test (RIDT) Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Rapid Influenza Diagnostic Test (RIDT) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rapid Influenza Diagnostic Test (RIDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rapid Influenza Diagnostic Test (RIDT) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.

The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.

Read the full market overview

This report provides an overview of the global Rapid Influenza Diagnostic Test (RIDT) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rapid Influenza Diagnostic Test (RIDT) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rapid Influenza Diagnostic Test (RIDT) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Rapid Influenza Diagnostic Test (RIDT) market.

Rapid Influenza Diagnostic Test (RIDT) Segment by Company

BD

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Wondfo

Beijing Wantai Biological Pharmacy

Rapid Influenza Diagnostic Test (RIDT) Segment by Type

Digital RIDTs

Conventional RIDT

Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals

POCT

Others

Rapid Influenza Diagnostic Test (RIDT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rapid Influenza Diagnostic Test (RIDT) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Rapid Influenza Diagnostic Test (RIDT) key companies, revenue, market share, and recent developments.

3. To split the Rapid Influenza Diagnostic Test (RIDT) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Rapid Influenza Diagnostic Test (RIDT) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rapid Influenza Diagnostic Test (RIDT) significant trends, drivers, influence factors in global and regions.

6. To analyze Rapid Influenza Diagnostic Test (RIDT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rapid Influenza Diagnostic Test (RIDT) industry.

Chapter 3: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Rapid Influenza Diagnostic Test (RIDT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Rapid Influenza Diagnostic Test (RIDT) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rapid Influenza Diagnostic Test (RIDT) Industry Trends Table 2. Rapid Influenza Diagnostic Test (RIDT) Industry Drivers Table 3. Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges Table 4. Rapid Influenza Diagnostic Test (RIDT) Industry Restraints Table 5. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Company (2021-2026) Table 7. Global Rapid Influenza Diagnostic Test (RIDT) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Rapid Influenza Diagnostic Test (RIDT) Key Company Manufacturing Base & Headquarters Table 9. Global Rapid Influenza Diagnostic Test (RIDT) Company, Product Type & Application Table 10. Global Rapid Influenza Diagnostic Test (RIDT) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Rapid Influenza Diagnostic Test (RIDT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Digital RIDTs Table 15. Significant Companies of Conventional RIDT Table 16. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type (2021-2026) Table 20. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of POCT Table 23. Significant Companies of Others Table 24. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application (2021-2026) Table 28. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application (2027-2032) Table 29. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Region (2021-2026) Table 32. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Region (2027-2032) Table 34. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Market Share by Country (2021-2026) Table 37. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Market Share by Country (2027-2032) Table 39. BD Company Information Table 40. BD Business Overview Table 41. BD Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 43. BD Recent Development Table 44. Abbot (Alere) Company Information Table 45. Abbot (Alere) Business Overview Table 46. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 48. Abbot (Alere) Recent Development Table 49. Quidel Company Information Table 50. Quidel Business Overview Table 51. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 53. Quidel Recent Development Table 54. Roche Company Information Table 55. Roche Business Overview Table 56. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 58. Roche Recent Development Table 59. Thermo Fisher Scientific Company Information Table 60. Thermo Fisher Scientific Business Overview Table 61. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 63. Thermo Fisher Scientific Recent Development Table 64. Meridian Bioscience Company Information Table 65. Meridian Bioscience Business Overview Table 66. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 68. Meridian Bioscience Recent Development Table 69. Analytik Jena Company Information Table 70. Analytik Jena Business Overview Table 71. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 73. Analytik Jena Recent Development Table 74. Princeton BioMeditech Corporation Company Information Table 75. Princeton BioMeditech Corporation Business Overview Table 76. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 78. Princeton BioMeditech Corporation Recent Development Table 79. BioMerieux Company Information Table 80. BioMerieux Business Overview Table 81. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 83. BioMerieux Recent Development Table 84. Sekisui Diagnostics Company Information Table 85. Sekisui Diagnostics Business Overview Table 86. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 88. Sekisui Diagnostics Recent Development Table 89. Response Biomedical Company Information Table 90. Response Biomedical Business Overview Table 91. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 92. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 93. Response Biomedical Recent Development Table 94. SA Scientific Company Information Table 95. SA Scientific Business Overview Table 96. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 97. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 98. SA Scientific Recent Development Table 99. DiaSorin (Focus Diagnostics) Company Information Table 100. DiaSorin (Focus Diagnostics) Business Overview Table 101. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 102. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 103. DiaSorin (Focus Diagnostics) Recent Development Table 104. Wondfo Company Information Table 105. Wondfo Business Overview Table 106. Wondfo Rapid Influenza Diagnostic Test (RIDT) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 107. Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 108. Wondfo Recent Development Table 109. Beijing Wantai Biological Pharmacy Company Information Table 110. Beijing Wantai Biological Pharmacy Business Overview Table 111. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 112. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 113. Beijing Wantai Biological Pharmacy Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Rapid Influenza Diagnostic Test (RIDT) Product Image Figure 2. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032) & (US$ Million) Figure 4. Global Rapid Influenza Diagnostic Test (RIDT) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Digital RIDTs Image Figure 8. Conventional RIDT Image Figure 9. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. POCT Image Figure 14. Others Image Figure 15. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application (2021-2032) Figure 18. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032) & (US$ Million) Figure 21. North America Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032) & (US$ Million) Figure 27. South America Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Digital RIDTs
  • Conventional RIDT
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbot (Alere)
  • Quidel
  • Roche
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • Analytik Jena
  • Princeton BioMeditech Corporation
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific
  • DiaSorin (Focus Diagnostics)
  • Wondfo
  • Beijing Wantai Biological Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
  1. 2.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
  2. 2.2 Rapid Influenza Diagnostic Test (RIDT) Industry Drivers
  3. 2.3 Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges
  4. 2.4 Rapid Influenza Diagnostic Test (RIDT) Industry Restraints
3 Rapid Influenza Diagnostic Test (RIDT) Market by Company
  1. 3.1 Global Rapid Influenza Diagnostic Test (RIDT) Company Revenue Ranking in 2025
  2. 3.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Company (2021-2026)
  3. 3.3 Global Rapid Influenza Diagnostic Test (RIDT) Company Ranking (2024-2026)
  4. 3.4 Global Rapid Influenza Diagnostic Test (RIDT) Company Manufacturing Base and Headquarters
  5. 3.5 Global Rapid Influenza Diagnostic Test (RIDT) Company Product Type and Application
  6. 3.6 Global Rapid Influenza Diagnostic Test (RIDT) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Rapid Influenza Diagnostic Test (RIDT) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Rapid Influenza Diagnostic Test (RIDT) Market by Type
  1. 4.1 Rapid Influenza Diagnostic Test (RIDT) Type Introduction
  2. 4.1.1 Digital RIDTs
  3. 4.1.2 Conventional RIDT
  4. 4.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type
  5. 4.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type (2021-2032)
5 Rapid Influenza Diagnostic Test (RIDT) Market by Application
  1. 5.1 Rapid Influenza Diagnostic Test (RIDT) Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 POCT
  4. 5.1.3 Others
  5. 5.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application
  6. 5.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Application (2021-2032)
  8. 5.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application (2021-2032)
6 Rapid Influenza Diagnostic Test (RIDT) Regional Value Analysis
  1. 6.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032)
  7. 6.3.2 North America Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032)
  10. 6.4.2 Europe Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032)
  16. 6.6.2 South America Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Country, 2025 VS 2032
7 Rapid Influenza Diagnostic Test (RIDT) Country-level Value Analysis
  1. 7.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Rapid Influenza Diagnostic Test (RIDT) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Abbot (Alere)
  8. 8.2.1 Abbot (Alere) Company Information
  9. 8.2.2 Abbot (Alere) Business Overview
  10. 8.2.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  12. 8.2.5 Abbot (Alere) Recent Developments
  13. 8.3 Quidel
  14. 8.3.1 Quidel Company Information
  15. 8.3.2 Quidel Business Overview
  16. 8.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  18. 8.3.5 Quidel Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Meridian Bioscience
  32. 8.6.1 Meridian Bioscience Company Information
  33. 8.6.2 Meridian Bioscience Business Overview
  34. 8.6.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  36. 8.6.5 Meridian Bioscience Recent Developments
  37. 8.7 Analytik Jena
  38. 8.7.1 Analytik Jena Company Information
  39. 8.7.2 Analytik Jena Business Overview
  40. 8.7.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  42. 8.7.5 Analytik Jena Recent Developments
  43. 8.8 Princeton BioMeditech Corporation
  44. 8.8.1 Princeton BioMeditech Corporation Company Information
  45. 8.8.2 Princeton BioMeditech Corporation Business Overview
  46. 8.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  48. 8.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 8.9 BioMerieux
  50. 8.9.1 BioMerieux Company Information
  51. 8.9.2 BioMerieux Business Overview
  52. 8.9.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  54. 8.9.5 BioMerieux Recent Developments
  55. 8.10 Sekisui Diagnostics
  56. 8.10.1 Sekisui Diagnostics Company Information
  57. 8.10.2 Sekisui Diagnostics Business Overview
  58. 8.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  60. 8.10.5 Sekisui Diagnostics Recent Developments
  61. 8.11 Response Biomedical
  62. 8.11.1 Response Biomedical Company Information
  63. 8.11.2 Response Biomedical Business Overview
  64. 8.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  66. 8.11.5 Response Biomedical Recent Developments
  67. 8.12 SA Scientific
  68. 8.12.1 SA Scientific Company Information
  69. 8.12.2 SA Scientific Business Overview
  70. 8.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  72. 8.12.5 SA Scientific Recent Developments
  73. 8.13 DiaSorin (Focus Diagnostics)
  74. 8.13.1 DiaSorin (Focus Diagnostics) Company Information
  75. 8.13.2 DiaSorin (Focus Diagnostics) Business Overview
  76. 8.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  78. 8.13.5 DiaSorin (Focus Diagnostics) Recent Developments
  79. 8.14 Wondfo
  80. 8.14.1 Wondfo Company Information
  81. 8.14.2 Wondfo Business Overview
  82. 8.14.3 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  84. 8.14.5 Wondfo Recent Developments
  85. 8.15 Beijing Wantai Biological Pharmacy
  86. 8.15.1 Beijing Wantai Biological Pharmacy Company Information
  87. 8.15.2 Beijing Wantai Biological Pharmacy Business Overview
  88. 8.15.3 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  90. 8.15.5 Beijing Wantai Biological Pharmacy Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst